Back to Index

CEREBRAINT Daily Market Report

Date Range: 2016-01-01 to 2026-10-26 | Evidence Type: Daily-only

DAILY-ONLY FALLBACK: This security has current daily OHLCV history but lacks the intraday files required by the legacy execution simulator. The page therefore reports observable daily-market evidence and current research candidates only. It does not claim intraday backtest performance or a trading recommendation.

Current Snapshot

Current Snapshot — CEREBRAINT Report
Metric Value
Latest closed session 2026-10-26
Latest close 2.3600
20-session average turnover 15167.83
Distance from 252-session high -76.04%

Trailing Price Returns

Trailing Price Returns — CEREBRAINT Report
Sessions Return
1 -4.84%
5 -9.58%
20 -14.49%
60 -20.81%
120 -43.27%
250 -74.76%

These are trailing observations ending on the latest closed session, not forward returns from a setup.

Current Market Intelligence Candidates

Current Market Intelligence Candidates — CEREBRAINT Report
Archetype Regime Primary horizon Strength First rejection risk
MEAN_REVERSION_CAPITULATION BEAR_PERSISTENT 20 9.81 Continued trend momentum breakdown
PRICE_DISLOCATION BEAR_PERSISTENT 120 0.19 Continued price deterioration or adverse fundamental evidence

Evidence Limits

Fundamental Research

Fundamental Research — CEREBRAINT Report
Field Value
Statement scope FULL_STATEMENTS
Latest annual period 2026-03-31
Statement completeness 100%
Revenue growth -83.28%
Net margin -1203.29%
Return on equity -76.91%
Debt/equity 0.47
Operating cash flow/net income 0.05
Free-cash-flow margin -65.34%
Trailing P/E N/A
Price/book N/A

Source: EODHD retrieved 2026-10-15T23:39:59.983688+00:00.

QA flags: balance_sheet_equation: difference=-21021000.00; weak_cash_conversion: operating cash flow/net income below 0.5

Missing statements mean data is unavailable. Balance-sheet equation flags require checking accounting definitions and units. Weak cash conversion and high leverage are financial risk observations, not necessarily data errors. A summary-only record cannot establish financial quality.

Provider-standardized figures are a research aid. Review consolidated filings, units, restatements, accounting policies, and QA flags before investment use.